Human prolactin receptors are insensitive to mouse prolactin: Implications for xenotransplant modeling of human breast cancer in mice

Journal of Endocrinology

Volumn 188, Issue 3, 2006, Pages 589-601

  Utama, F E ^c   LeBaron, M J ^c   Neilson, L M ^c   Sultan, A S ^c   Parlow, A F ^a   Wagner, K U ^b   Rui, H ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN KINASE B; STAT3 PROTEIN; STAT5 PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER GROWTH; CELL LINE; CELL PROLIFERATION; CELL STRAIN COS7; CELL STRAIN MCF 7; DISEASE COURSE; DRUG RESPONSE; ENZYME ACTIVATION; GENE INDUCTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VALIDATION PROCESS; XENOGRAFT; XENOTRANSPLANTATION;

ANALYSIS OF VARIANCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPORATION; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, NUDE; MODELS, ANIMAL; NEOPLASM TRANSPLANTATION; PROLACTIN; PROTEIN BINDING; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; STAT5 TRANSCRIPTION FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 33645213701     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06560     Document Type: Article

References (56)

1. Ball RK, Friis RR, Schoenenberger CA, Doppler W & Groner B 1988 Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. Embo Journal 7 2089-2095.
2. Ben-Jonathan N, Liby K, McFarland M & Zinger M 2002 Prolactin as an autocrine/paracrine growth factor in human cancer. Trends in Endocrinological Metabolism 13 245-250.
3. Bernichtein S, Kayser C, Dillner K, Moulin S, Kopchick JJ, Martial JA, Norstedt G, Isaksson O, Kelly PA & Goffin V 2003 Development of pure prolactin receptor antagonists. Journal of Biological Chemistry 278 35988-35999.
4. Biswas R & Vonderhaar BK 1987 Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Research 47 3509-3514.
5. Brelje TC, Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG & Sorenson RL 1993 Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132 879-887.
6. Chen NY, Holle L, Li W, Peirce SK, Beck MT & Chen WY 2002 In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. International Journal of Oncology 20 813-818.
7. Clevenger CV, Furth PA, Hankinson SE & Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocrine Reviews 24 1-27.
8. DaSilva L, Howard OM, Rui H, Kirken RA & Farrar WL 1994 Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. Journal of Biological Chemistry 269 18267-18270.
9. Davis JA & Linzer DI 1989 A mutant lactogenic hormone binds, but does not activate, the prolactin receptor. Molecular Endocrinology 3 949-953.
10. Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ & Bernard-Gallon DJ 1999 Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochemical and Biophysical Research Communications 258 284-291.
11. Gill S, Peston D, Vonderhaar BK & Shousha S 2001 Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. Journal of Clinical Pathology 54 956-960.
12. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
13. Goffin V, Norman M & Martial JA 1992 Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Molecular Endocrinology 6 1381-1392.
14. Goffin V, Binart N, Clement-Lacroix P, Bouchard B, Bole-Feysot C, Edery M, Lucas BK, Touraine P, Pezet A, Maaskant R et al. 1999 From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genetic Analyst 15 189-201.
15. Gura T 1997 Systems for identifying new drugs are often faulty. Science 278 1041-1042.
16. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B & Speizer FE 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 91 629-634.
17. Happ B & Groner B 1993 The activated mammary gland specific nuclear factor (MGF) enhances in vitro transcription of the beta-casein gene promoter. Journal of Steroid Biochemistry and Molecular Biology 47 21-30.
18. Hwang P, Guyda H & Friesen H 1972 Purification of human prolactin. Journal of Biological Chemistry 247 1955-1958.
19. Kim JB, O'Hare MJ & Stein R 2004 Models of breast cancer: is merging human and animal models the future? Breast Cancer Research 6 22-30.
20. Kindblom J, Dillner K, Sahlin L, Robertson F, Ormandy C, Tornell J & Wennbo H 2003 Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 144 2269-2278.
21. Kirken RA, Malabarba MG, Xu J, Liu X, Farrar WL, Hennighausen L, Larner AC, Grimley PM & Rui H 1997 Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. Journal of Biological Chemistry 272 14098-14103.
22. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Corey L, Richardson A & Weinberg RA 2004 Reconstruction of functionally normal and malignant human breast tissues in mice. PNAS 101 4966-4971.
23. Leung CK & Shiu RP 1981 Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Research 41 546-551.
24. Llovera M, Touraine P, Kelly PA & Goffin V 2000 Involvement of prolactin in breast cancer: redefining the molecular targets. Experimental Gerontology 35 41-51.
25. Malarkey WB, Kennedy M, Allred LE & Milo G 1983 Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. Journal of Clinical Endocrinological Metabolism 56 673-677.
26. Maus MV, Reilly SC & Clevenger CV 1999 Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 140 5447-5450.
27. Mehta RR, Graves JM, Hart GD, Shilkaitis A & Das Gupta TK 1993 Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Research Treatment 25 65-71.
28. Mitchell TJ, Whittaker SJ & John S 2003 Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary syndrome. Cancer Research 63 9048-9054.
29. Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL & Lazarus L 1984 Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Research 44 1963-1968.
30. Naylor MJ, Lockefeer JA, Horseman ND & Ormandy CJ 2003 Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 20 111-114.
31. Nevalainen MT, Xie J, Bubendorf L, Wagner KU & Rui H 2002a Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Molecular Endocrinology 16 1108-1124.
32. Nevalainen MT, Xie J, Bubendorf L, Wagner KU & Rui H 2002b Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Molecular Endocrinology 16 1108-1124.
33. Nicoll CS, Mayer GL & Russell SM 1986 Structural features of prolactins and growth hormones that can be related to their biological properties. Endocrine Reviews 7 169-203.
34. Ogren L & Talamantes F 1988 Prolactins of pregnancy and their cellular source. International Reviews in Cytology 112 1-65.
35. Peirce SK & Chen WY 2004 Human prolactin and its antagonist, hPRL-G129R, regulate box and bcl-2 gene expression in human breast cancer cells and transgenic mice. Oncogene 23 1248-1255.
36. Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE & Holly JM 2004 Prolactin acts as a potent survival factor for human breast cancer cell lines. British Journal of Cancer 91 305-311.
37. Posner BI, Kelly PA, Shiu RP & Friesen HG 1974 Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology 95 521-531.
38. Reynolds C, Montone KT, Powell CM, Tomaszewski JE & Clevenger CV 1997 Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138 5555-5560.
39. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP & Schuler LA 2003 Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22 4664-4674.
40. Shiu RP 1981 Prolactin, pituitary hormones, and breast cancer. In Hormones and Breast Cancer, pp 185-196. Eds MC Pike, PK Siiteri, CW Welsch. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press.
41. Sinha YN 1995 Structural variants of prolactin: occurrence and physiological significance. Endocrine Reviews 16 354-369.
42. Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ, Desai SB & Atkin SL 1998 Short-term primary culture of epithelial cells derived from human breast tumours. British Journal of Cancer 78 1421-1429.
43. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT & Rui H 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24 746-760.
44. Teilum K, Hoch JC, Goffin V, Kinet S, Martial JA & Kragelund BB 2005 Solution structure of human prolactin. Journal of Molecular Biology 351 810-823.
45. Tworoger SS, Eliassen AH, Rosner B, Sluss P & Hankinson SE 2004 Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Research 64 6814-6819.
46. Vomachka AJ, Pratt SL, Lockefeer JA & Horseman ND 2000 Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19 1077-1084.
47. Vonderhaar BK 1989 Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Letters 47 105-110.
48. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocrine-Related Cancer 6 389-404.
49. Vonderhaar BK & Biswas R 1987 Prolactin effects and regulation of its receptors in human mammary tumor cells. In Cellular and Molecular Biology of Mammary Cancer, pp 205-219. Eds D Medina, W Kidwell, G Hepner & E Anderson. New York, NY, USA: Plenum.
50. Wagner KU 2004 Models of breast cancer: quo vadis, animal modeling? Breast Cancer Research 6 31-38.
51. Wennbo H & Tornell J 2000 The role of prolactin and growth hormone in breast cancer. Oncogene 19 1072-1076.
52. Wennbo H, Kindblom J, Isaksson OG & Tornell J 1997a Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138 4410-4415.
53. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG & Tornell J 1997b Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenie mice. Journal of Clinical Investigation 100 2744-2751.
54. Xie J, LeBaron MJ, Nevalainen MT & Rui H 2002 Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. Journal of Biological Chemistry 277 14020-14030.
55. Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, Hannon JM, Hennighausen L, Kirken RA & Rui H 2001 Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression. Molecular and Cellular Endocrinology 183 151-163.
56. Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T et al. 2000 Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. Journal of Biological Chemistry 275 33937-33944.